MedTrace Logo

MRI of the Liver With Eovist

NCT01215838 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2013-10-14

No results posted yet for this study

Summary

The purpose of this study is to determine if a new magnetic resonance (MR) protocol is better at diagnosing liver lesions.

Conditions

Sponsors & Collaborators

  • Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

    collaborator INDUSTRY

  • University of Washington

    lead OTHER

Principal Investigators

  • Orpheus Kolokythas, MD · University of Washington

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-08-31
Completion
2012-01-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01215838 on ClinicalTrials.gov